Displaying 511 - 540 of 2455
The research describes a high incidence of TB among household contacts, that is, people who live in the same residence as a person who has previously been diagnosed with the disease
The study used IBMO chimeric antigens in the diagnosis in regions where the protozoa 'Crithidia sp. LVH-60A' and 'Trypanosoma cruzi' coexist
Scientists from IOC/Fiocruz contribute to the description of specimens found in fish from three Brazilian states; it does not pose a health risk
Article about the Early Warning System for Outbreaks with Pandemic Potential (ÆSOP) shows how the tool can support health authorities in making decisions in epidemiological surveillance
Ao comparar com as estimativas nacionais, a pesquisa da Fiocruz Bahia concluiu que a cidade apresenta alta prevalência de doença de Chagas crônica e alto risco de transmissão.
The aim is to strengthen national production and the access to the treatment of immune-mediated inflammatory diseases, triggered by imbalances in the immune system
The regulatory submission to the Brazilian Health Regulatory Agency (Anvisa) will be carried out by Farmanguinhos
The objective is to jointly develop new medicines, in addition to offering joint courses and improving postgraduate programs
Institutions seek to improve surveillance alternatives to combat Amazon winter diseases and the presence of antimicrobial-resistant bacteria in hospital environments
Data indicate that mortality is associated not only with the age group and severity of the case, but also with social and regional inequalities
No Brasil a submissão regulatória na Agência Nacional de Vigilância Sanitária (Anvisa) se dará pelo Instituto de Tecnologia em Fármacos (Farmanguinhos/Fiocruz)
